HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Is The Tide Turning For EU Prebiotics And Probiotics Regulation?

Executive Summary

More EU countries than you might think allow the terms "prebiotic" and "probiotic" on food supplement labels, suggests a survey from consultancy firm Sandwalk Bioventures. HBW Insight speaks to Sandwalk's managing director, Luis Gosalbez, about a possible move towards liberalization in the region among member states, as well as a way forward for EU regulators lagging behind this localized movement. 

You may also be interested in...



Italy's Health Ministry Sets Up Supplements Committee To Improve Oversight Of Growing Sector

Italy has set up a new committee to oversee its booming food supplements market with a remit of consumer protection and advising on proportionate regulation.

Sweden’s Essity Launches UK Menopause VMS Range, Leukoplast Eco Line Extensions

Essity has launched in the UK an Issviva branded e-commerce platform and dietary supplements range and two sustainable plaster additions to the Leukoplast wound-care line.

Nestlé Discovers Gut Bacteria Strain Suggesting Opportunities For Infant Nutrition

Scientists at Nestlé’s research division think that they have found new bifidobacterium longum strains that have unique ability to utilize both key components of human milk and fibers from solid food, opening up new opportunities for “next generation nutritional solutions” like probiotics targeting the crucial weaning period of child development.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151139

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel